BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26497796)

  • 1. Rho kinase inhibitor AMA0526 improves surgical outcome in a rabbit model of glaucoma filtration surgery.
    Van de Velde S; Van Bergen T; Vandewalle E; Kindt N; Castermans K; Moons L; Stalmans I
    Prog Brain Res; 2015; 220():283-97. PubMed ID: 26497796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
    Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Rho-Associated Kinase Prevents Pathological Wound Healing and Neovascularization After Corneal Trauma.
    Sijnave D; Van Bergen T; Castermans K; Kindt N; Vandewalle E; Stassen JM; Moons L; Stalmans I
    Cornea; 2015 Sep; 34(9):1120-9. PubMed ID: 26075454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of different VEGF isoforms in scar formation after glaucoma filtration surgery.
    Van Bergen T; Vandewalle E; Van de Veire S; Dewerchin M; Stassen JM; Moons L; Stalmans I
    Exp Eye Res; 2011 Nov; 93(5):689-99. PubMed ID: 21907194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery.
    Ko JA; Komatsu K; Minamoto A; Kondo S; Okumichi H; Hirooka K; Kiuchi Y
    Curr Eye Res; 2023 Sep; 48(9):826-835. PubMed ID: 37216470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery.
    Li Z; Van Bergen T; Van de Veire S; Van de Vel I; Moreau H; Dewerchin M; Maudgal PC; Zeyen T; Spileers W; Moons L; Stalmans I
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5217-25. PubMed ID: 19474408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery.
    Cheng WS; Chen CL; Chen JT; Lin LT; Pao SI; Chen YH; Lu DW
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32993110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Everolimus on Scar Formation in Glaucoma Filtering Surgery in a Rabbit Model.
    Cinik R; Yüksel N; Pirhan D; Aslan MŞ; Subaşı C; Karaöz E
    Curr Eye Res; 2016 Nov; 41(11):1438-1446. PubMed ID: 27116538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor.
    Ibrahim DG; Ko JA; Iwata W; Okumichi H; Kiuchi Y
    Cell Biochem Funct; 2019 Mar; 37(2):113-124. PubMed ID: 30773659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Lovastatin on Wound-Healing Modulation After Glaucoma Filtration Surgery in a Rabbit Model.
    Park JH; Yoo C; Kim YY
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1871-7. PubMed ID: 27082302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Porcine Chondrocyte-Derived Extracellular Membrane (CDECM) on Postoperative Wound Healing in an Experimental Rabbit Model of Glaucoma Filtration Surgery.
    Kim JL; Lee HS; Lee Y; Kang MS; Lee SJ; Yang JW
    Curr Eye Res; 2017 Jun; 42(6):897-907. PubMed ID: 28085505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model.
    Chen YH; Liang CM; Chen CL; Chen JT; Chang YH; Lu DW; Chien KH; Tai MC
    Acta Ophthalmol; 2013 Nov; 91(7):e506-15. PubMed ID: 23764119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A p38 MAPK inhibitor improves outcome after glaucoma filtration surgery.
    Nassar K; Tura A; Lüke J; Lüke M; Grisanti S; Grisanti S
    J Glaucoma; 2015 Feb; 24(2):165-78. PubMed ID: 25493622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The possibility of selective Rho-associated kinase (ROCK) inhibitors as a medical treatment for glaucoma].
    Honjo M
    Nippon Ganka Gakkai Zasshi; 2009 Nov; 113(11):1071-81. PubMed ID: 19994585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts.
    Futakuchi A; Inoue T; Fujimoto T; Inoue-Mochita M; Kawai M; Tanihara H
    Exp Eye Res; 2016 Aug; 149():107-115. PubMed ID: 27394186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery.
    Wong TT; Mead AL; Khaw PT
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1097-103. PubMed ID: 12601035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
    Meyer-ter-Vehn T; Sieprath S; Katzenberger B; Gebhardt S; Grehn F; Schlunck G
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4895-904. PubMed ID: 17065504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluripotent epigenetic regulator OBP-801 maintains filtering blebs in glaucoma filtration surgery model.
    Yamamoto Y; Mukai A; Ikushima T; Urata Y; Kinoshita S; Hamuro J; Ueno M; Sotozono C
    Sci Rep; 2020 Dec; 10(1):20936. PubMed ID: 33262357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferation effects of Sirolimus sustained delivery film in rabbit glaucoma filtration surgery.
    Yan ZC; Bai YJ; Tian Z; Hu HY; You XH; Lin JX; Liu SR; Zhuo YH; Luo RJ
    Mol Vis; 2011; 17():2495-506. PubMed ID: 21976960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).
    Sherwood MB
    Trans Am Ophthalmol Soc; 2006; 104():478-92. PubMed ID: 17471357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.